Home > Boards > US Listed > Biotechs > Agile Therapeutics, Inc. (AGRX)

Realistic price target if approved?

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Papalaka Member Profile
 
Followed By 368
Posts 23,426
Boards Moderated 1
Alias Born 10/29/09
160x600 placeholder
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 3/17/2020 3:50:49 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 3/16/2020 4:32:49 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 3/6/2020 8:01:44 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 2/26/2020 4:31:06 PM
Agile Therapeutics, Inc. (Nasdaq: AGRX) to Ring Nasdaq Stock Market Closing Bell on Wednesday, February 26, 2020 GlobeNewswire Inc. - 2/25/2020 11:41:43 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 2/21/2020 4:47:51 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 2/21/2020 4:27:33 PM
Agile Therapeutics Announces Pricing of $45 Million Underwritten Public Offering of Common Stock GlobeNewswire Inc. - 2/21/2020 8:35:10 AM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 2/20/2020 5:28:57 PM
Annual Report (10-k) Edgar (US Regulatory) - 2/20/2020 4:38:25 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 2/20/2020 4:28:46 PM
Agile Therapeutics Announces Proposed Underwritten Public Offering of Common Stock GlobeNewswire Inc. - 2/20/2020 4:14:47 PM
Agile Therapeutics Reports Fourth Quarter and Full Year 2019 Financial Results GlobeNewswire Inc. - 2/20/2020 4:01:10 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 2/18/2020 8:50:44 AM
FDA Approves Agile Therapeutics, Inc.’s Twirla® (levonorgestrel and ethinyl estradiol) Transdermal System – A New Weekly... GlobeNewswire Inc. - 2/14/2020 6:46:11 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/14/2020 3:57:03 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/13/2020 5:11:57 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/13/2020 12:51:41 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 2/12/2020 8:01:37 AM
Agile Therapeutics, Inc. Enters into up to $35 Million Loan Facility with Perceptive Advisors GlobeNewswire Inc. - 2/10/2020 4:30:10 PM
Agile Therapeutics to Present at the 38th Annual J.P. Morgan Healthcare Conference in San Francisco GlobeNewswire Inc. - 1/6/2020 8:00:10 AM
Agile Therapeutics Strengthens Commercial Leadership Team GlobeNewswire Inc. - 1/2/2020 8:00:10 AM
Agile Therapeutics to Present at Biotech Showcase™ 2020 in San Francisco GlobeNewswire Inc. - 12/19/2019 4:05:10 PM
Agile Therapeutics Announces FDA Extension of Twirla® NDA Review Period GlobeNewswire Inc. - 11/14/2019 4:30:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/8/2019 4:39:45 PM
Papalaka   Tuesday, 11/19/19 12:34:22 PM
Re: None
Post # of 982 
Realistic price target if approved?

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist